Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001595215-16-000004
Filing Date
2016-10-05
Accepted
2016-10-05 12:53:34
Documents
1
Effectiveness Date
2016-10-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7215
  Complete submission text file 0001595215-16-000004.txt   8266
Mailing Address 10581 ROSELLE STREET, SUITE 115 SAN DIEGO CA 92121
Business Address 10581 ROSELLE STREET, SUITE 115 SAN DIEGO CA 92121 858-925-5619
Aspyrian Therapeutics, Inc. (Filer) CIK: 0001595215 (see all company filings)

EIN.: 272624716 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-258981 | Film No.: 161921859